linked an anti‐CD73 scFv to the ganglioside GD2 CAR in NK‐92 cells via a cleavable and tumor‐sensitive linker, which specifically release an anti‐CD73 antibody into the GBM TME (Figure 5B). This evidence concerns the gene NT5E and glioblastoma.